Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp48191_8k.htm |
Exhibit 99.1
|
Press Release
|
 |
|
www.shire.com
|
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE
OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO
SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS
OF SUCH JURISDICTION.
Updated Rule 2.10 Announcement
Dublin, Ireland – July 28, 2014 – In accordance with Rule 2.10 of The City Code on Takeovers and Mergers, Shire plc (LSE: SHP, NASDAQ: SHPG) confirms that, as at close of business on July 25, 2014, it had in issue 589,524,300 ordinary shares of 5 pence each (excluding ordinary shares held in treasury), with ISIN JE00B2QKY057, which carry voting rights of one vote per share.
Shire plc has an American Depositary Receipt program for which Citibank, N.A. acts as Depositary. One American Depositary Share (“ADS”) represents three ordinary shares of 5 pence each, with ISIN US82481R1068. The ADSs trade on the NASDAQ Global Select Market.
For further information please contact:
|
Investor Relations
|
||
|
Jeff Poulton
|
jpoulton@shire.com
|
+1 781 482 0945
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX